EU-Startups· David Cendon Garcia·· 2 days agoTop DealsAI Score62
Microbiotica raises €42M Series C for inflammatory bowel disease treatment
New treatment for inflammatory bowel disease lands Microbiotica €42 million
AI Overview
British clinical-stage biopharma company Microbiotica announced the first close of a €42 million Series C round led by British Business Bank.
Why it matters
Microbiotica's Series C first close shows how genomics and machine learning are moving microbiome drug candidates into Phase 2 trials.
Source:EU-Startups · eu-startups.com
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing